Skye Bioscience, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
SKYE on Nasdaq
Location
11250 El Camino Real, Suite 100, San Diego, CA

Insiders trading volume in the past year

Skye Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Andrew J. Schwab Director $60.1M -$1.75M -2.83% Oct 28, 2024
5AM Partners VII, LLC 10%+ Owner $60.1M +$14.8M +32.6% Sep 11, 2024
Versant Ventures III, LLC 10%+ Owner $9.39M Aug 18, 2023
Emerald Health Sciences Inc. 10%+ Owner $3.17M Nov 10, 2022
Punit Dhillon Chief Executive Officer, Director $1.69M -$414K -19.7% Nov 15, 2024
Paul A. Grayson Director $1.3M -$432K -25% Nov 15, 2024
Kaitlyn Arsenault Chief Financial Officer $830K -$217K -20.7% Nov 15, 2024
Tuan Tu Diep Chief Development Officer $410K -$97.7K -19.2% Nov 15, 2024
Margaret Dalesandro Director Feb 29, 2024
Praveen Tyle Director Feb 29, 2024
Keith Wayne Ward Director Feb 29, 2024
Puneet S. Arora Chief Medical Officer Sep 3, 2024
Annalisa Jenkins Director Oct 28, 2024
James L. Heppell Director Sep 14, 2021
Sukhwinder Singh Rai Director Jan 5, 2023
Deborah H. Charych Director Oct 28, 2024
Karen L. Smith Director Oct 28, 2024

Recent Insider Transactions by Companies or Individuals for Skye Bioscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.